This may be old news to many here, but I hadn't no
Post# of 145796
![](/assets/46931549/no_avatar_available_thumb.jpg)
Quote:
CytoDyn brings this Complaint to protect 67 patients with treatment-resistant HIV and 25 patients with non-alcoholic steatohepatitis (a kind of liver disease) that are currently receiving CytoDyn’s drug in clinical trials. The safety of these patients is being threatened by Amarex, the clinical research organization managing the trials under contracts with CytoDyn.
So even the opening salvo is a request to protect patients' safety. From my lofty bastion in my armchair (or, more likely, my couch) I am not allowed to comment on why that would be, but I'd be pleased to hear any savvy explanations.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)